{'fraction_non_alphanumeric': 0.034532374100719423, 'fraction_numerical': 0.02158273381294964, 'mean_word_length': 5.566037735849057, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Integrated profiling of diffuse large B‐cell lymphoma with 7q gain

To characterize diffuse large B‐cell lymphoma (DLBCL) with chromosome 7 gains, we combined clinical data with genomic, RNA and miRNA profiling. Gains were associated with age >60 years, female gender, a trend for higher complete response rate, lower death rate, and better overall survival in patients treated with R‐CHOP. Lesions were inversely associated with bone marrow involvement and number of extra‐nodal sites. Differentially expressed transcripts were enriched of genes belonging to specific pathways and miRNAs targets. MIR96, MIR182, MIR589, MIR25 were shown significantly up‐regulated in 7q+ DLBCL by real‐time PCR.